| (3-(carbazole-9H)Phenyl)Pinacol ester |
870119-58-7 |
|
| METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE |
78471-43-9 |
|
| N-(HYDROXYMETHYL)TRIFLUOROACETAMIDE |
50667-69-1 |
|
| 2-Methylbenzofuro[2,3-b]pyridin-8-yl trifluoromethanesulfonate |
1609373-98-9 |
|
| Nintedanib impurity I |
334951-61-0 |
|
| Z-L-Phe(4-tBu)-OH |
1270292-81-3 |
|
| 2-(Di-1-adaMantylphosphino)-3,6-diMethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl, Min. 95% AdBrettPhos |
1160861-59-5 |
|
| |
| 3-Hydroxybutanoic acid magnesium salt |
586976-57-0 |
|
| TRANS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID |
1124-13-6 |
|
| 3,3-diMethyl-6-nitrobenzo[c][1,2]oxaborol-1(3H)-ol |
1266084-47-2 |
|
| Isoastragaloside IV |
136033-55-1 |
|
| |
| ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE |
39736-29-3 |
|
| N,N'-BIS[2-[5-(DIMETHYLAMINOMETHYL)FURFURYLTHIO]ETHYL]-2-NITRO-1,1-ETHENDIAMINE |
72126-78-4 |
|
| CarbaMic acid, [2-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethyl]-, 1,1-diMethylethyl ester |
452339-71-8 |
|
| |
| Tri(pyridin-4-yl)amine |
153467-50-6 |
|
| p-(Hexafluoro-2-hydroxypropyl)styrene |
2386-82-5 |
|
| N-Boc-O-tosyl hydroxylamine |
105838-14-0 |
|
| NLEKRIPRBRHEPC-AWEZNQCLSA-N |
68223-08-5 |
|
| 4-bromo-2,3,5,6-tetrafluorobenzaldehyde |
108574-98-7 |
|
| 2-(6-aminopyridin-3-yl)propan-2-ol |
843643-03-8 |
|
| Trenbolone cyclohexylmethylcarbonate |
23454-33-3 |
|
| Selank peptide |
129954-34-3 |
|
| Polyethylene glycol monomethallyl ether |
31497-33-3 |
|
| Mal-PEG8-NHS ester |
2055033-05-9 |
|
| Sofosbuvir metabolites |
1859162-80-3 |
|
| Tris[4-(1H-imidazol-1-yl)-phenyl]amine |
1258947-79-3 |
|
| mono-(6-(1,6-hexamethylenediamine)-6-deoxy)-β-Cyclodextrin |
131991-61-2 |
|
